BRF S.A. (BRFS)
Last Price$3.33.1%
Market Cap$5,511.5M
BRFS Rating
BRFS Quality rating performance
BRFS Intrinsic Value
Key Highlights:
As of Mar 07, 2025 BRFS Relative Value is $7.6, which is undervalued by 128.6%, compared to current share price of $3.3.
As of Mar 07, 2025 BRFS DCF Value is $3.0, which is overvalued by 8.5%, compared to current share price of $3.3.
BRFS Share Price History
1W 8.1%
1M (7.8%)
6M (23.7%)
YTD 28.2%
1Y 1.8%
3Y 19.4%
5Y (20.2%)
10Y (82.8%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
BRFS Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$5,511.5M
$7,707.0M
R$58.3B
R$6,386.2M
Shares Outstanding
1,660M
Employees
N/A
Growth (CAGR)
14.7%
18.2%
N/A
27.3%
16.0%
Profitability
24.5%
10.1%
14.7%
11.0%
188.9%
Intrinsic Value
$5.3 (58.4% undervalued)
$3.0
$7.6
($78.6)
100.5%
Return on Capital
Financial Health
R$12.7B
2.0x
1.6x
133.4%
Dividends
N/A
0.0%
0.0%
Nov 27, 2024
Earnings
May 05, 2025
BEAT by 9.3%
BEAT by 9.1%
(38.9%)
4 Beat & 6 Miss
BRFS Stock Financials
BRFS Income Statement Metrics
Annual
Quarterly
LTM
BRFS Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$787.4M +93.1% YoY
Capital Expenditure (CAPEX)
($483.0M) +21.8% YoY
Free Cash Flow (FCF)
$304.4M +708.4% YoY
BRFS Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$10.7B (0.4%) YoY
Cost of revenue
$8,950.6M (2.0%) YoY
Pre-tax income
$396.7M (29.2%) YoY
(3.7%) margin
BRFS Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$11.8B
Current assets ($5,338.8M, 45.3% of total)
$1,997.9M (17.0%)
$980.4M (8.3%)
Other current assets
$2,360.5M (20.0%)
Non-current assets ($6,442.1M, 54.7% of total)
$86.0M (0.7%)
$3,005.1M (25.5%)
$565.6M (4.8%)
Other non-current assets
$2,785.5M (23.6%)
Financial position
$2,901.4M
Cash & Short-term
Investments
Total Debt
BRFS Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
BRFS Earnings Surprises
Crunching data... Almost there!
BRFS Dividends
BRFS Dividend Yield
Crunching data... Almost there!
BRFS Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with BRFS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$5,511.5M | 7.3 | $5.3 58.4% undervalued | 1.8% | R$58.3B | R$6,386.2M | 8.0% | 11.0% | 24.5% | 21.0% | 133.4% | |
$38.8B | 5.6 | $137.9 328.4% undervalued | (3.3%) | $25.8B | $3,020.0M | (3.0%) | 11.7% | 34.7% | 5.7% | 39.0% | |
$35.9B | 6.9 | $76.4 18.5% undervalued | 4.0% | $19.9B | $2,800.1M | (1.5%) | 14.1% | 34.9% | 13.1% | 153.7% | |
$25.0B | 4.3 | $54.1 53.9% overvalued | 2.7% | $8,788.0M | $815.2M | 7.1% | 9.3% | 38.4% | 0.6% | 17.1% | |
$22.2B | 5.8 | $47.5 42.5% overvalued | 23.6% | $6,723.7M | $647.0M | 0.9% | 9.6% | 38.5% | 8.3% | 81.7% | |
$16.5B | 5.4 | $28.2 6.0% overvalued | (8.6%) | $11.9B | $890.6M | (1.8%) | 7.5% | 16.7% | 7.6% | 35.5% | |
$13.0B | 6.4 | $23.1 15.1% overvalued | 1.4% | $11.9B | $1,525.7M | (2.0%) | 12.8% | 27.4% | 36.6% | 25.3% | |
$13.0B | 7.5 | $52.1 4.6% overvalued | 68.6% | $17.9B | $1,514.0M | 2.9% | 8.5% | 12.8% | 18.5% | 4.6% | |
$12.5B | 5.9 | $55.3 32.2% undervalued | 2.8% | $10.1B | $984.0M | 9.1% | 9.7% | 30.3% | 6.7% | 196.2% | |
$8,890.2M | 7.3 | $29.5 57.2% overvalued | 12.2% | $2,098.7M | $125.5M | 21.0% | 6.0% | 36.0% | 52.9% | (568.5%) | |
$8,873.3M | 7.3 | $161.5 19.2% undervalued | 19.5% | $7,430.0M | $1,135.0M | (8.9%) | 15.3% | 25.9% | 14.8% | 52.3% |
FAQ
What is BRF S.A. (BRFS) stock rating?
As of today, BRF S.A. has a stock rating of 7 (out of 10), which is considered Great.
is BRF S.A. (BRFS) a good stock to buy?
As of today, BRF S.A. has a Great stock rating, which is 58.4% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.